Related Experiment Video
Updated: Jan 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Post-pandemic increase in pediatric invasive pneumococcal disease driven by serotype 3
Jorge Benito Arribas1, Celina García Pérez1, Emilia Cercenado2
1Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.
Pediatric invasive pneumococcal disease (IPD) declined during COVID-19 but resurged, driven by serotype 3. This serotype caused severe illness and fatalities despite high vaccination rates, highlighting the need for updated vaccines.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Vaccinology
Background:
- Invasive pneumococcal disease (IPD) remains a significant pediatric health concern.
- The COVID-19 pandemic altered respiratory pathogen circulation and pediatric infectious disease patterns.
Purpose of the Study:
- To analyze trends in pediatric IPD before and after the COVID-19 pandemic.
- To identify pathogens, severity, and outcomes associated with pediatric IPD.
Main Methods:
- Retrospective study of children under 18 with confirmed IPD.
- Data collected from January 2018 to April 2023 in Madrid, Spain.
- Analysis of clinical, microbiological, and vaccination data, comparing pre- and post-pandemic periods.
Main Results:
- A decline in IPD cases was observed during the early COVID-19 pandemic, with a subsequent rise in incidence and severity post-pandemic.
- Serotype 3 was the most common cause of IPD, strongly associated with severe disease, PICU admissions, and one fatality.
- Severe cases and PICU admissions were significantly more frequent in the post-pandemic period, even in fully vaccinated children.
Conclusions:
- A resurgence of pediatric IPD, particularly due to serotype 3, was observed after the COVID-19 pandemic.
- Serotype 3 IPD is linked to increased severity and poor outcomes, irrespective of vaccination status.
- Improved vaccine formulations and adaptive immunization strategies are crucial for managing pediatric IPD.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

